feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Japan to Add Extra Costs to Common Rx Drugs

Japan to Add Extra Costs to Common Rx Drugs

12 Jan

•

Summary

  • 77 ingredients in prescription drugs will incur extra patient costs.
  • Measure aims for fairness and to reduce insurance burden.
  • Additional fees start March 2027; some groups exempt.
Japan to Add Extra Costs to Common Rx Drugs

Starting March 2027, Japan plans to implement additional patient charges on around 1,100 prescription medications that contain 77 specific ingredients. These "OTC-like drugs" are similar in composition and effect to over-the-counter products but have been covered by public health insurance. The Ministry of Health, Labor and Welfare announced this proposal to ensure fairness for individuals purchasing over-the-counter medicines and to lessen the financial strain on the working population through insurance premiums.

The new system will require patients to pay an additional "special fee" of 25% of the drug cost, on top of their usual 10% to 30% copayment, with public insurance covering the remaining 75%. This change is expected to increase costs for patients with a 30% copayment to approximately 1.6 times their current expense. The ministry estimates this measure will reduce national medical expenses by about 90 billion yen annually.

trending

Baggage handler trapped on plane

trending

Texans rolling into playoffs

trending

Trent Brown returns for playoffs

trending

Pittman accused in synagogue fire

trending

Tottenham close to Gallagher deal

trending

Red Wings beat Hurricanes

trending

Anthropic releases Claude Cowork feature

trending

Celtics Pacers game on Peacock

trending

Red Wings honor Fedorov

However, certain groups will be exempt from these special fees. These include children, individuals undergoing cancer treatment, patients with intractable diseases, and those managing chronic conditions that require special consideration. The implementation of these additional charges is slated for March 2027, following the formal establishment of the new fee structure.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
OTC-like drugs are prescription medications covered by public insurance that have similar ingredients and effects to over-the-counter products.
The charges aim to ensure fairness with over-the-counter drug purchases and reduce the insurance premium burden on the working population.
The additional fees are scheduled to begin in March 2027.

Read more news on

Business and Economyside-arrow

You may also like

Japan Exports Surge 6.1%, Defying Economic Woes

17 Dec, 2025 • 147 reads

article image

Fake Doctor Arrested in Osaka Clinic Scandal

12 Dec, 2025 • 120 reads

article image

India's New Labor Codes Earn Global Nod

23 Nov, 2025 • 231 reads

article image

India's Wheat Fields Hit Record High

18 Nov, 2025 • 200 reads

article image

Antibiotic Resistance Accelerates Globally, Urgent Action Required

18 Nov, 2025 • 324 reads

article image